Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patients

被引：0
|
作者：
Hiroko Shindo
Shinya Maekawa
Kazuki Komase
Ryota Sueki
Mika Miura
Makoto Kadokura
Kuniaki Shindo
Fumitake Amemiya
Takatoshi Kitamura
Yasuhiro Nakayama
Taisuke Inoue
Minoru Sakamoto
Shun-ichi Okada
Yasuhiro Asahina
Namiki Izumi
Masao Honda
Shuichi Kaneko
Nobuyuki Enomoto
机构：
[1] University of Yamanashi,First Department of Internal Medicine
[2] Musashino Red Cross Hospital,Division of Gastroenterology and Hepatology
[3] Kanazawa University Graduate School of Medicine,Department of Gastroenterology
来源：
Hepatology International | 2012年 / 6卷
关键词：
HCV; Protease inhibitor; Naturally occurring viral resistance mutations;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：482 / 490
页数：8
相关论文
共 50 条
  • [21] Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world
    Oh, Jae Young
    Kim, Byung Seok
    Lee, Chang Hyeong
    Song, Jeong Eun
    Lee, Heon Ju
    Park, Jung Gil
    Hwang, Jae Seok
    Chung, Woo Jin
    Jang, Byoung Kuk
    Kweon, Young Oh
    Tak, Won Young
    Park, Soo Young
    Jang, Se Young
    Suh, Jeong Ill
    Kwak, Sang Gyu
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (04): : 794 - 801
  • [22] Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice
    Osawa, Mitsutaka
    Uchida, Takuro
    Imamura, Michio
    Teraoka, Yuji
    Fujino, Hatsue
    Nakahara, Takashi
    Ono, Atsushi
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Miki, Daiki
    Tsuge, Masataka
    Hiramatsu, Akira
    Abe-Chayama, Hiromi
    Hayes, C. Nelson
    Makokha, Grace Naswa
    Aikata, Hiroshi
    Ishida, Yuji
    Tateno, Chise
    Miyayama, Yohei
    Hijikata, Makoto
    Chayama, Kazuaki
    JOURNAL OF GENERAL VIROLOGY, 2019, 100 (07): : 1123 - 1131
  • [23] Reversion of naturally occurring high-level resistance mutations to NS3 protease inhibitors in two treatment-naive individuals infected with hepatitis C virus
    Bagaglio, Sabrina
    Messina, Emanuela
    Uberti-Foppa, Caterina
    Merli, Marco
    Della Torre, Liviana
    Lazzarin, Adriano
    Hasson, Hamid
    Morsica, Giulia
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (06) : 1448 - 1450
  • [24] Efficacy and safety of elbasvir plus grazoprevir combination therapy in Japanese patients infected with hepatitis C virus genotype 1b
    Takeuchi, Yasue
    Akuta, Norio
    Sezaki, Hitomi
    Suzuki, Fumitaka
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Saitoh, Satoshi
    Suzuki, Yoshiyuki
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    HEPATOLOGY RESEARCH, 2019, 49 (03) : 256 - 263
  • [25] Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Guangzhou, China: Predominance of Genotype 1b and Increasing Incidence of Genotype 6a
    Yuan, Guosheng
    Liu, Junwei
    Hu, Chengguang
    Huang, Huaping
    Qi, Minghua
    Wu, Tao
    Liang, Weifang
    Li, Yi-Ping
    Zhang, Yong-Yuan
    Zhou, Yuanping
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 43 (02) : 775 - 787
  • [26] Impact of Chronic Hepatitis C Virus Genotype 1b Infection on Triglyceride Concentration in Serum Lipoprotein Fractions
    Nagano, Tomohisa
    Seki, Nobuyoshi
    Tomita, Yoichi
    Sugita, Tomonori
    Aida, Yuta
    Itagaki, Munenori
    Sutoh, Satoshi
    Abe, Hiroshi
    Tsubota, Akihito
    Aizawa, Yoshio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (09): : 20576 - 20594
  • [27] Grazoprevir/Elbasvir Treatment in Liver or Kidney Transplant Recipients with Genotype 1b Hepatitis C Virus Infection
    Lai, Ping-Chin
    Chen, Cheng-Hsu
    Jeng, Long-Bin
    Yu, Tung-Min
    Tsai, Shang-Feng
    Wu, Ming-Ju
    Cheng, Shao-Bin
    Yang, Sheng-Shun
    Lee, Teng-Yu
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (02)
  • [28] Amino Acid Substitutions in the Hepatitis C Virus Core Region of Genotype 1b Are the Important Predictor of Severe Insulin Resistance in Patients Without Cirrhosis and Diabetes Mellitus
    Akuta, Norio
    Suzuki, Fumitaka
    Hirakawa, Miharu
    Kawamura, Yusuke
    Yatsuji, Hiromi
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (06) : 1032 - 1039
  • [29] Analysis of Genotype 1b Hepatitis C Virus IRES in Serum and Peripheral Blood Mononuclear Cells in Patients Treated with Interferon and Ribavirin
    Bukowska-Osko, Iwona
    Cortes, Kamila Caraballo
    Pawelczyk, Agnieszka
    Ploski, Rafal
    Fic, Maria
    Perlejewski, Karol
    Demkow, Urszula
    Berak, Hanna
    Horban, Andrzej
    Laskus, Tomasz
    Radkowski, Marek
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [30] Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b
    Akuta, Norio
    Suzuki, Fumitaka
    Kawamura, SuzukiYusuke
    Yatsuji, Hiromi
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (11) : 1686 - 1695
12345